Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 43063-474

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 43063-474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

43063474 Label (43063474)

43063474 Label (43063474)
This is a description of a medication identified as Atorvastatin Calcium USP. The medicine is sold as tablets containing 10mg of Atorvastatin. The package contains 30 tablets and the item is maintained by Pharmaceuticals incorporated. The item's NDC number is 43063-474-30 and the reorder number is 104492. The medication's expiration date is 03/2021, and the indicated lot number is C20A23. Users are urged to contact a medical professional for advice concerning any side effects that may arise from using the medication, and the FDA can also investigate possible side effects by contacting their hotline at 1-800-FDA-1088.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
The text describes a graph of the Cumulative Hazard (%) for Atorvastatin. The hazard is shown in percentages at 10 and 15 percent. A Hazard Ratio of 0.53 with a confidence interval between 0.45 to 0.83 is also displayed for Atorvastatin. The graph shows the time to the first primary endpoint through four years of followup from year one to year five.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
The text provides statistical data on the percentage of subjects experiencing Evert in response to Horvastatin and Sorvastatin treatment. The HR (Hazard Ratio) for Horvastatin and Sorvastatin is also given, along with the confidence interval and P-value. The graph represents the time taken for the first major cardiovascular endpoint in years.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.